S100B Protein in Clinical Diagnostics: Assay Specificity
Open Access
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (1) , 249-251
- https://doi.org/10.1373/clinchem.2003.027367
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Serum S100βCancer, 2003
- Heterogenous S-100B Protein Expression Patterns in Malignant Melanoma and Association with Serum Protein LevelsOncology, 2003
- Diagnostic value and prognostic significance of protein S‐100β, melanoma‐inhibitory activity, and tyrosinase/MART‐1 reverse transcription‐polymerase chain reaction in the follow‐up of high‐risk melanoma patientsCancer, 2003
- Differential expression of S100 proteins in the developing human hippocampus and temporal cortexMicroscopy Research and Technique, 2003
- Visualization of S100B‐positive neurons and glia in the central nervous system of EGFP transgenic miceJournal of Comparative Neurology, 2003
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJournal of Clinical Investigation, 2001
- Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) ActivationJournal of Biological Chemistry, 2000
- Differential expression of S100B and S100A61 in the human fetal and aged cerebral cortexDevelopmental Brain Research, 2000
- A New Specific Method for Measuring S-100B in SerumThe International Journal of Biological Markers, 2000
- RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin PolypeptidesPublished by Elsevier ,1999